A detailed history of Convergence Investment Partners, LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 678 shares of ELV stock, worth $252,853. This represents 0.1% of its overall portfolio holdings.

Number of Shares
678
Previous 687 1.31%
Holding current value
$252,853
Previous $372,000 5.38%
% of portfolio
0.1%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$500.12 - $562.29 $4,501 - $5,060
-9 Reduced 1.31%
678 $352,000
Q2 2024

Aug 01, 2024

SELL
$497.49 - $547.8 $10,447 - $11,503
-21 Reduced 2.97%
687 $372,000
Q1 2024

May 03, 2024

SELL
$464.61 - $519.96 $1,393 - $1,559
-3 Reduced 0.42%
708 $367,000
Q4 2023

Feb 05, 2024

SELL
$433.51 - $488.06 $2,601 - $2,928
-6 Reduced 0.84%
711 $335,000
Q3 2023

Nov 02, 2023

BUY
$414.13 - $475.93 $7,040 - $8,090
17 Added 2.43%
717 $312,000
Q2 2023

Jul 26, 2023

SELL
$436.33 - $496.2 $17,889 - $20,344
-41 Reduced 5.53%
700 $311,000
Q1 2023

May 09, 2023

SELL
$446.3 - $502.2 $1,785 - $2,008
-4 Reduced 0.54%
741 $341,000
Q4 2022

Feb 03, 2023

SELL
$465.23 - $546.77 $34,892 - $41,007
-75 Reduced 9.15%
745 $382,000
Q3 2022

Nov 08, 2022

SELL
$445.98 - $507.0 $67,342 - $76,557
-151 Reduced 15.55%
820 $373,000
Q2 2022

Aug 05, 2022

BUY
$444.32 - $529.84 $39,100 - $46,625
88 Added 9.97%
971 $469,000
Q1 2022

Apr 26, 2022

SELL
$428.44 - $502.48 $2,999 - $3,517
-7 Reduced 0.79%
883 $434,000
Q4 2021

Jan 25, 2022

SELL
$370.08 - $467.67 $8,881 - $11,224
-24 Reduced 2.63%
890 $413,000
Q3 2021

Oct 25, 2021

BUY
$357.51 - $398.13 $20,020 - $22,295
56 Added 6.53%
914 $341,000
Q2 2021

Jul 19, 2021

SELL
$352.19 - $401.9 $11,270 - $12,860
-32 Reduced 3.6%
858 $328,000
Q1 2021

Apr 30, 2021

SELL
$287.7 - $371.31 $2,877 - $3,713
-10 Reduced 1.11%
890 $319,000
Q4 2020

Feb 05, 2021

BUY
$270.17 - $333.15 $2,431 - $2,998
9 Added 1.01%
900 $289,000
Q3 2020

Oct 28, 2020

BUY
$245.73 - $284.63 $1,228 - $1,423
5 Added 0.56%
891 $239,000
Q2 2020

Jul 30, 2020

BUY
$203.3 - $300.59 $180,123 - $266,322
886 New
886 $233,000
Q1 2020

Apr 23, 2020

SELL
$174.68 - $307.74 $156,862 - $276,350
-898 Closed
0 $0
Q4 2019

Jan 22, 2020

SELL
$234.82 - $306.42 $1,643 - $2,144
-7 Reduced 0.77%
898 $271,000
Q3 2019

Oct 22, 2019

SELL
$237.69 - $310.48 $9,032 - $11,798
-38 Reduced 4.03%
905 $217,000
Q2 2019

Jul 23, 2019

BUY
$236.25 - $293.76 $8,977 - $11,162
38 Added 4.2%
943 $266,000
Q1 2019

May 01, 2019

SELL
$248.42 - $317.42 $5,465 - $6,983
-22 Reduced 2.37%
905 $260,000
Q4 2018

Feb 13, 2019

BUY
$249.0 - $296.25 $23,157 - $27,551
93 Added 11.15%
927 $243,000
Q3 2018

Nov 13, 2018

SELL
$238.27 - $274.12 $17,393 - $20,010
-73 Reduced 8.05%
834 $228,000
Q2 2018

Aug 07, 2018

BUY
$220.13 - $245.16 $660 - $735
3 Added 0.33%
907 $216,000
Q1 2018

May 14, 2018

BUY
$215.63 - $258.19 $194,929 - $233,403
904 New
904 $199,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $89.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.